Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy

Published:2012-12-26 Issue:1 Volume:15 Page:E33-E39
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Bosch W.¹,Poowanawittayakom N.²,Chaikriangkrai K.²,Mendez J.¹,Hellinger W.C.¹,Gonwa T.A.³,Krishna M.⁴,Pungpapong S.³

Affiliation:

1. Division of Infectious Disease; Mayo Clinic; Jacksonville; Florida; USA

2. Department of Medicine; Siriraj Hospital; Mahidol University; Bangkok; Thailand

3. Department of Transplantation; Mayo Clinic; Jacksonville; Florida; USA

4. Department of Pathology; Mayo Clinic; Jacksonville; Florida; USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12048/fullpdf

Reference29 articles.

1. Induction immunosuppression improved long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data;Cai;Transplantation,2010

2. New immunosuppressive strategies and the risk of infection;Mueller;Transpl Infect Dis,2008

3. Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials;Webster;Transplantation,2004

4. Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis;Szczech;J Am Soc Nephrol,1997

5. The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group;Szczech;Ann Intern Med,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Cureus;2024-01-10

2. Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Life;2023-05-28

3. Molecular Epidemiology of Rifampicin-Resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF Assay in Renal Transplant Recipients: A Single-Center Experience;Experimental and Clinical Transplantation;2023-04

4. Hepatobiliary Tract Infections;Principles and Practice of Transplant Infectious Diseases;2019

5. Mycobacterium tuberculosisafter solid organ transplantation: A review of more than 2000 cases;Clinical Transplantation;2018-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3